Sweden And Copenhagen
UPPSALA, Sweden and COPENHAGEN, Denmark, August 22, 2011 -
Phadia AB and Biomonitor A/S announced today a collaboration in the field of immunogenicity testing and monitoring of patients treated with biopharmaceutical drugs.